Reolysin® Enters Clinical Trial for Patients With Metastatic Colorectal Cancer

Immunotherapy - United Kingdom
doi 10.2217/1750743x.1.2.167
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Future Medicine Ltd

Related search

Colorectal Cancer Genomic Biomarkers in the Clinical Management of Patients With Metastatic Colorectal Carcinoma

2020English

Phase I Trial of Oxaliplatin Plus S-1 Chemotherapy in Patients With Metastatic Colorectal Cancer

Oncology Letters
Cancer ResearchOncology
2010English

SIR-Spheres® Y-90 Resin Microspheres in Chemotherapy Refractory or Intolerant Patients With Metastatic Colorectal Cancer

Global and Regional Health Technology Assessment
Health Policy
2019English

Therapy for Metastatic Colorectal Cancer

Oncologist
Cancer ResearchMedicineOncology
2006English

Angiogenesis Genotyping and Clinical Outcome During Regorafenib Treatment in Metastatic Colorectal Cancer Patients

Scientific Reports
Multidisciplinary
2016English

Biomarker Signatures Correlate With Clinical Outcome in Refractory Metastatic Colorectal Cancer Patients Receiving Bevacizumab and Everolimus

Molecular Cancer Therapeutics
Cancer ResearchOncology
2015English

Capecitabine and Irinotecan as First- Line Chemotherapy for Patients With Metastatic Colorectal Cancer

Journal of IMAB - Annual Proceeding (Scientific Papers)
Dentistry
2011English

Major Surgery in Patients With Metastatic Colorectal Cancer in Western Europe

Journal of Gastrointestinal Cancer
OncologyGastroenterology
2011English

Transarterial Chemoembolisation in the Treatment of Patients With Metastatic Colorectal Cancer

I.P. Pavlov Russian Medical Biological Herald
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy